Results 91 to 100 of about 46,751 (115)

The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRAS^G12D-driven non-small cell lung cancer. [PDF]

Mol Cancer
McDaid WJ, Wilson L, Adderley H, Martinez-Lopez A, Baker MJ, Searle J, Ginn L, Budden T, Aldea M, Marinello A, Aredo JV, Viros A, Besse B, Wakelee HA, Blackhall F, Castillo-Lluva S, Lindsay CR, Malliri A.   +17 more
europepmc   +1 more source

Intravesical instillation-based mTOR-STAT3 dual targeting for bladder cancer treatment. [PDF]

J Exp Clin Cancer Res
Lee DH, Yoo JK, Um KH, Ha W, Lee SM, Park J, Kye MJ, Suh J, Choi JW.   +8 more
europepmc   +1 more source

Post-translational modifications orchestrate mTOR-driven cell death in cardiovascular disease. [PDF]

Front Cardiovasc Med
Guo J, Wu Y, Wan Z, Zhang Z.
europepmc   +1 more source

p53: The Multifaceted Roles of Covalent Modifications in Cancer. [PDF]

Pharmaceuticals (Basel)
Grigoreva TA, Romanova AA, Tribulovich VG, Pestov NB, Oganov RA, Kovaleva DK, Korneenko TV, Barlev NA.   +7 more
europepmc   +1 more source

Conventional and Alternative B Lymphopoiesis: Multiple Roads to Immunity. [PDF]

Stem Cell Rev Rep
Chiron-Margerie A, Bessoles S, Sarrabayrouse G, Krzysiek R, Hacein-Bey-Abina S.   +4 more
europepmc   +1 more source

Ribosome dysregulation and intervention in age-related infertility. [PDF]

Cell Rep Med
Li J, Wang H, Zhu P, Chen H, Zuo H, Liu C, Liu L, Ye X, Feng G, Wu Y, Liu Q, Yang T, Keefe DL, Bai X, Shang W, Wu X, Liu L.   +16 more
europepmc   +1 more source

Analysis of data on biosimilar prescription rates in rheumatology practice from a reference center in Turkey. [PDF]

Sci Rep
Kaplan H, Cengiz G, Kara H, Cüce İ, Kirnap M, Çaliş M.   +5 more
europepmc   +1 more source

Prevalence and spectrum of germline BRCA1 and BRCA2 mutations in multiethnic cohort of breast cancer patients in Brunei Darussalam. [PDF]

PLoS One
Matusin SNI, Mumin N, Zainal Abidin H, Mohd Jaya FN, Lu ZH, Haji Abdul Hamid MRW.   +5 more
europepmc   +1 more source

Interferon signaling pathways in health and disease. [PDF]

Mol Biomed
Wen C, Lan Q, Wang Y, Ni Y, Wong AST, Liu D.   +5 more
europepmc   +1 more source

Molecular Alterations and Pathways in Intrahepatic Cholangiocarcinoma: Available Evidence and New Perspectives. [PDF]

Int J Mol Sci
Astore M, Fabbri L, Monte A, Deiana C, Rizzo A, Tavolari S, Deserti M, Brandi G, Palloni A, Frega G.   +9 more
europepmc   +1 more source